These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects. Vuong TD, Stroes ES, Willekes-Koolschijn N, Rabelink TJ, Koomans HA, Joles JA. Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937 [Abstract] [Full Text] [Related]
3. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria. Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C. Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011 [Abstract] [Full Text] [Related]
4. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia. Rahman M, Salamatullah Q, Ferdous Z, Hussain MA. Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998 [Abstract] [Full Text] [Related]
9. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia. Joven J, Vilella E. Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484 [Abstract] [Full Text] [Related]
10. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome. de Zeeuw D, Gansevoort RT, Dullaart RP, de Jong PE. J Hypertens Suppl; 1995 Jul; 13(1):S53-8. PubMed ID: 18800457 [Abstract] [Full Text] [Related]
11. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis. Kaysen GA, Jones H, Joles JA, van Tol A. Miner Electrolyte Metab; 1996 Jul; 22(1-3):31-8. PubMed ID: 8676821 [Abstract] [Full Text] [Related]
18. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M. N Engl J Med; 1990 Aug 30; 323(9):579-84. PubMed ID: 2381443 [Abstract] [Full Text] [Related]